Cellcentric Ltd.
Clinical trials sponsored by Cellcentric Ltd., explained in plain language.
-
New drug trial targets tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called CCS1477 (inobrodib) in people with advanced blood cancers that have returned or stopped responding to standard treatments. The study will give the drug alone and in combination to about 250 patients to check if it is s…
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for patients with aggressive blood cancer that has stopped responding to treatment
Disease control Recruiting nowThis study is testing whether adding a new drug called inobrodib to two standard medications can help control multiple myeloma that has come back and no longer responds to available therapies. It will involve about 100 adults whose cancer has progressed despite trying several oth…
Phase: PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC